Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Exact Sciences schedules first quarter 2021 earnings call | ||||||||||||||||||||||||||
By: PR Newswire Association LLC. - 08 Apr 2021 | Back to overview list |
|||||||||||||||||||||||||
MADISON, Wis., April 8, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its first quarter 2021 financial results after the close of the U.S. financial markets on May 4, 2021. Following the release, company management will host a webcast and conference call at 5 p.m. EDT to discuss financial results and business progress.
An archive of the webcast will be available at www.exactsciences.com. A replay of the conference call will be available by calling 800-585-8367 domestically or 416-621-4642 internationally. The access code for the replay of the call is 5789488. The webcast, conference call and replay are open to all interested parties. About Exact Sciences Corp. A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook. Contact: View original content to download multimedia:http://www.prnewswire.com/news-releases/exact-sciences-schedules-first-quarter-2021-earnings-call-301264655.html SOURCE EXACT SCIENCES CORP |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
Copyright 2021 PR Newswire Association LLC. | Back to overview list |